Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationLymphomaBone Marrow TransplantationStem CellsLiver TransplantationGraft vs Host DiseaseLymphoma, Non-HodgkinKidney TransplantationTreatment OutcomeHematologic NeoplasmsMultiple MyelomaGraft SurvivalHematopoietic Stem CellsCell TransplantationMelphalanCombined Modality TherapyHematopoietic Stem Cell MobilizationLymphoma, B-CellTransplantation ChimeraTissue DonorsRecurrenceRemission InductionWhole-Body IrradiationHeart TransplantationCord Blood Stem Cell TransplantationMesenchymal Stem Cell TransplantationBusulfanMyeloablative AgonistsRetrospective StudiesCyclophosphamideLung TransplantationSalvage TherapyAntineoplastic Combined Chemotherapy ProtocolsLymphoma, T-CellAntigens, CD34Immunosuppressive AgentsDisease-Free SurvivalHodgkin DiseaseLymphoma, Large B-Cell, DiffuseSurvival AnalysisSurvival RateLymphoma, FollicularTime FactorsHistocompatibility TestingOrgan TransplantationGranulocyte Colony-Stimulating FactorTransplantation ImmunologyEmbryonic Stem CellsGraft RejectionCarmustineLeukemiaBone Marrow PurgingLeukapheresisEtoposideGraft vs Tumor EffectFollow-Up StudiesAdult Stem CellsHistocompatibilityTransplantationCytarabineIslets of Langerhans TransplantationCell DifferentiationTransplantation, IsogeneicPancreas TransplantationLeukemia, Myeloid, AcuteVincristinePrognosisGraft vs Leukemia EffectMyelodysplastic SyndromesBurkitt LymphomaVidarabineHematopoiesisBone Marrow CellsCells, CulturedBone MarrowImmunosuppressionLymphoma, Mantle-CellPluripotent Stem CellsLiving DonorsPrednisoneHLA AntigensNeoplasm, ResidualMesenchymal Stromal CellsNeural Stem CellsAntibodies, Monoclonal, Murine-DerivedHepatic Veno-Occlusive DiseaseFlow CytometryStem Cell NicheChimerismCell SeparationLymphocyte TransfusionHematologic DiseasesAntineoplastic AgentsAntineoplastic Agents, AlkylatingT-Lymphocytes